NCT00703183View on ClinicalTrials.gov

Safety and Tolerability of ACU-4429

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Healthy

Interventions

DRUG

ACU-4429

administered as a single dose, orally

DRUG

matching placebo

administered as a single dose, orally

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc, Dallas

Sponsors

Lead Sponsor

Kubota Vision Inc.

All Listed Sponsors

lead

Kubota Vision Inc.

INDUSTRY